Lovelace Respiratory Research Institute
Lovelace Respiratory Research Institute is dedicated to serving humanity through research on the prevention, treatment, and cure of respiratory diseases. It aims to advance public health via biomedical science research, development, and service, with a focus on respiratory health issues, inhalation toxicology, and related fields.
Industries
Nr. of Employees
large (251-1000)
Lovelace Respiratory Research Institute
Patents
Inhalable dry powder cytidine analogue composition and method of use as a treatment for cancer
US-11266599-B2
View Details
Inhalable dry powder cytidine analogue composition and method of use as a treatment for cancer
US-11266599-B2
View DetailsServices
Program and project management support for federal and commercial programs, including acquisition-level program implementation and change management.
IT consulting, enterprise service-desk, network operations, web application development, systems administration, and database development/administration.
End-to-end preclinical research services including inhalation toxicology, aerosolization testing, animal model studies, and GLP-compliant study execution.
Operational management and execution of human clinical trials through affiliated clinical research capabilities.
Support for regulatory submissions, GLP compliance, quality assurance, and interactions with federal regulatory agencies to advance therapies and devices.
Design, engineering, and operational management for containment laboratories, animal housing, and specialized research infrastructure.
Program and project management support for federal and commercial programs, including acquisition-level program implementation and change management.
IT consulting, enterprise service-desk, network operations, web application development, systems administration, and database development/administration.
End-to-end preclinical research services including inhalation toxicology, aerosolization testing, animal model studies, and GLP-compliant study execution.
Operational management and execution of human clinical trials through affiliated clinical research capabilities.
Support for regulatory submissions, GLP compliance, quality assurance, and interactions with federal regulatory agencies to advance therapies and devices.
Design, engineering, and operational management for containment laboratories, animal housing, and specialized research infrastructure.
Expertise Areas
- Inhalation toxicology
- Preclinical safety and toxicology
- Respiratory disease research
- Aerosol science and inhalation drug delivery
Key Technologies
- BSL-3 containment laboratories
- Aerosol exposure systems and aerosol science
- Inhalation drug delivery systems
- Preclinical animal models (small and large species)
News & Updates
Lovelace Biomedical will participate in the American Society of Gene & Cell Therapy conference in Washington, D.C., from May 10-13, at Booth #305.
Lovelace Biomedical will present research on lung fibrosis at the ATS 2017 conference in Washington, D.C., from May 19-24.
Lovelace was featured for its work on canine models for Alzheimer’s disease.
NBC News highlighted Dr. Kajon’s study published in Emerging Infectious Diseases advocating for broader vaccination.
An article discussing the challenges in preclinical research for pulmonary fibrosis.
Lovelace Biomedical will participate in the American Society of Gene & Cell Therapy conference in Washington, D.C., from May 10-13, at Booth #305.
Lovelace Biomedical will present research on lung fibrosis at the ATS 2017 conference in Washington, D.C., from May 19-24.
Lovelace was featured for its work on canine models for Alzheimer’s disease.
NBC News highlighted Dr. Kajon’s study published in Emerging Infectious Diseases advocating for broader vaccination.
An article discussing the challenges in preclinical research for pulmonary fibrosis.